Comparison of the Efficacy of Ultrasound-Guided Corticosteroid Injection and Paraffin Therapy in Carpal Tunnel Syndrome

Beylikduzu State Hospital

Status: Enrolling

Conditions: Carpal Tunnel Syndrome

Treatments: Other: No intervention

Study type: Observational

Funder types: Other

Identifiers

NCT06658886

BeylikduzuStateH9

Details and patient eligibility

About

The aim of this study is to compare the efficacy of paraffin therapy, a physical therapy modality, and ultrasound-guided corticosteroid injection in the treatment of carpal tunnel syndrome, the most common entrapment neuropathy. By doing so, the study will evaluate the effectiveness and feasibility of these two alternative, low-side-effect treatments for managing this frequently encountered condition.

Full description

A total of 46 patients, aged 18-65, diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies, will be included in the study.Pain levels will be assessed using the Visual Analog Scale (VAS), and functional impairment will be measured with the Boston Carpal Tunnel Syndrome Questionnaire (BCTQ). Electrophysiological evaluations will be performed by a neurology specialist at the 1st and 3rd month follow-ups outside of working hours and without being billed to the Social Security Institution (SGK). VAS, BCTQ scores, and electrophysiological parameters will be evaluated at baseline, and at the 4th and 12th-week follow-ups post-treatment. Electrophysiological measurements will include median nerve distal motor latency (MMNDL), median nerve distal sensory latency (MNSDL), sensory nerve conduction velocity (SNCV), compound muscle action potential (CMAP), and sensory nerve action potential (SNAP) amplitudes.

Enrollment: 46 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients aged 18-65.
• Diagnosed with mild to moderate carpal tunnel syndrome based on electrophysiological studies.
• Received either ultrasound-guided corticosteroid injection or paraffin therapy.
• Symptoms persisting for at least 3 months.

Exclusion criteria

• Diagnosis of other conditions causing neuropathic symptoms (e.g., polyneuropathy, brachial plexopathy, thoracic outlet syndrome).
• History of previous injection or surgery for carpal tunnel syndrome.

Trial design

46 participants in 2 patient groups

Paraffin treatment group

Description:

Patients with carpal tunnel syndrome who have received paraffin therapy

Treatment:

Other: No intervention

Injection group

Description:

Patients with carpal tunnel syndrome who have applied ultrasound-guided steroid injection

Treatment:

Other: No intervention